ACADACADIA Pharmaceuticals Inc.
29.50USD-2.35%Mkt Cap: 5.05B $P/E: 13.233d ago
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America. The company offers NUPLAZID (pimavanserin), a se…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap5.05B $
Enterprise Value4.12B $
Revenue (TTM)1.14B $
Gross Profit982.51M $
Net Income (TTM)391.00M $
Revenue/Share6.689 USD
Last Price29.50 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees796
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS0042251084
Valuation
P/E (Trailing)13.23
P/E (Forward)32.68
PEG50.86
EV/EBITDA41.88
EV/Revenue3.62
P/S4.39
P/B3.83
EPS (TTM)2.14
EPS (Forward)0.89
52W Range
19.6987% of range30.96
52W High30.96 USD
52W Low19.69 USD
Profitability
Gross Margin91.69%
Oper. Margin12.29%
EBITDA Margin8.64%
Profit Margin36.49%
ROE31.86%
ROA25.00%
Growth
Revenue Growth16.40%
Earnings Growth13.30%
Cash Flow & Leverage
Operating CF109.84M $
CapEx (TTM)4.69M $
FCF Margin6.03%
FCF Yield1.36%
Net Debt-882.62M $
Net Debt/EBITDA-8.97
Balance Sheet
Debt/Equity0.04
Current Ratio3.39
Quick Ratio3.11
Book Value/Sh7.591 USD
Cash/Share5.551 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)33.85 USD
Upside (mean)+14.7%
Target Range17.00 USD – 49.00 USD
$17.00+14.7% to mean$49.00
# Analysts20
Ownership
Shares Out.171.24M
Float128.35M
Insiders0.33%
Institutions99.76%
Short Interest
Short Ratio7.5d
Short % Float9.92%
Short % Out.6.28%
Shares Short10.81M
Short (prev mo.)10.95M
Technical
SMA 5025.69 (+14.8%)
SMA 20024.12 (+22.3%)
Beta0.84
S&P 52W Chg18.16%
Avg Vol (30d)1.57M
Avg Vol (10d)1.66M
Technical Indicators
RSI (14)65.5
MACD1.3316
MACD Signal1.2461
MACD Hist.+0.0855
BB Upper31.07 USD
BB Middle27.41 USD
BB Lower23.76 USD
BB Width26.68%
ATR (14)1.062 USD
Vol Ratio (20d)0.66x